Kaur Maninder, Aggarwal Aruna
Assistant Professor, Department of Microbiology, Sri Guru Ram Das Institute of Medical Sciences and Research , Amritsar, India .
J Clin Diagn Res. 2013 Apr;7(4):642-5. doi: 10.7860/JCDR/2013/5081.2872. Epub 2013 Apr 1.
The present study was carried out to assess the prevalence of the Extended Spectrum Beta Lactamases (ESBLs) and to characterize the ESBL types which were prevalent in our hospital.
Five hundred gram negative isolates which belonged to the family, Enterobacteriaceae, which were isolated during the study period of 2009 to 2011, were investigated for ESBL production. Clinical isolates from urine (344), pus (109), blood (15), IV/ central line tip (10), sputum (12) and body fluid (10) specimens were processed. The organisms which were identified, included E.coli (351), Klebsiella pneumoniae (74), Klebsiella oxytoca (21), Proteus mirabilis (15), Proteus vulgaris (9), Enterobacter spp (15) and Citrobacterspp (15). Antimicrobial susceptibility testing was done. The ESBL detection was carried out for all the isolates by the CLSI confirmatory method. The MIC of ceftazidime and ceftazidime plus clavulanic acid was determined by the E-test. Molecular typing of the ESBLs was performed by multiplex PCR among 93 ESBL isolates.
45.8% isolates were found to be ESBL producers by the CLSI confirmatory method and they were confirmed by the E-test ESBL strips. A majority of E.coli in the study possessed the CTX-M genes (59.32%). Among the Klebsiella isolates, a majority were co producers of the ESBL genes; either 2 or all the 3 genes co-existed together.
An indiscriminate use of the higher antibiotics should be restricted as far as possible. The infection control programmes should be monitored continuously in hospitals, to contain these ESBL producers. We are reporting the presence of all types of ESBL genes among the Enterobacteriaceae isolates from our hospital setting.
开展本研究以评估超广谱β-内酰胺酶(ESBLs)的流行情况,并对我院流行的ESBL类型进行特征分析。
对2009年至2011年研究期间分离出的500株属于肠杆菌科的革兰氏阴性菌进行ESBL产生情况调查。对尿液(344份)、脓液(109份)、血液(15份)、静脉/中心静脉导管尖端(10份)、痰液(12份)和体液(10份)标本中的临床分离株进行处理。鉴定出的菌株包括大肠埃希菌(351株)、肺炎克雷伯菌(74株)、产酸克雷伯菌(21株)、奇异变形杆菌(15株)、普通变形杆菌(9株)、肠杆菌属(15株)和柠檬酸杆菌属(15株)。进行了抗菌药物敏感性试验。采用CLSI确证法对所有分离株进行ESBL检测。通过E-test法测定头孢他啶及头孢他啶加克拉维酸的最低抑菌浓度(MIC)。对93株ESBL分离株采用多重PCR进行ESBL分子分型。
采用CLSI确证法发现45.8%的分离株为ESBL产生菌,E-test ESBL试纸条进一步证实了这一结果。研究中的大多数大肠埃希菌携带CTX-M基因(59.32%)。在克雷伯菌分离株中,大多数是ESBL基因的共同产生菌;2种或所有3种基因共同存在。
应尽可能限制不合理使用高级抗生素。医院应持续监测感染控制方案,以控制这些ESBL产生菌。我们报告了我院肠杆菌科分离株中存在所有类型的ESBL基因。